Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity

BACKGROUND: Nanoparticles (NPs) incorporating drug formulations can be used to facilitate passage through biological barriers including the blood–brain barrier (BBB) and increase drug delivery and bioavailability. Hence, NP-based administration may enhance the efficiency of current antipsychotics. E...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugasi, L., Grinberg, I., Rudnick-Glick, S., Okun, E., Einat, H., Margel, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580026/
https://www.ncbi.nlm.nih.gov/pubmed/33087104
http://dx.doi.org/10.1186/s12951-020-00709-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580026/
https://www.ncbi.nlm.nih.gov/pubmed/33087104
http://dx.doi.org/10.1186/s12951-020-00709-z

Ejemplares similares